Which drug is a meglitinide?

Prepare for the Glucose Management Test with interactive quizzes featuring multiple choice questions, hints, and detailed explanations. Boost your confidence and be exam-ready!

Multiple Choice

Which drug is a meglitinide?

Explanation:
Meglitinides are insulin secretagogues that prompt the pancreas to release insulin by closing ATP-dependent potassium channels on beta cells, which depolarizes the cell and triggers calcium influx leading to insulin release. They are rapid-acting and short-lived, so they’re taken just before meals to boost the post-meal insulin response. Repaglinide is a meglitinide, so it fits this mechanism and timing perfectly. The other drugs do not act as insulin secretagogues: metformin lowers hepatic glucose production, pioglitazone improves insulin sensitivity via PPAR gamma, and acarbose delays carbohydrate absorption in the gut.

Meglitinides are insulin secretagogues that prompt the pancreas to release insulin by closing ATP-dependent potassium channels on beta cells, which depolarizes the cell and triggers calcium influx leading to insulin release. They are rapid-acting and short-lived, so they’re taken just before meals to boost the post-meal insulin response.

Repaglinide is a meglitinide, so it fits this mechanism and timing perfectly. The other drugs do not act as insulin secretagogues: metformin lowers hepatic glucose production, pioglitazone improves insulin sensitivity via PPAR gamma, and acarbose delays carbohydrate absorption in the gut.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy